| Directed evolution of multiple genomic loci allows the prediction of antibiotic resistance Á Nyerges, B Csörgő, G Draskovits, B Kintses, P Szili, G Ferenc, T Révész, ... Proceedings of the National Academy of Sciences 115 (25), E5726-E5735, 2018 | 105 | 2018 |
| Enzyme promiscuity shapes adaptation to novel growth substrates GI Guzmán, TE Sandberg, RA LaCroix, Á Nyerges, H Papp, M de Raad, ... Molecular systems biology 15 (4), e8462, 2019 | 71 | 2019 |
| Exploring protein hotspots by optimized fragment pharmacophores D Bajusz, WS Wade, G Satała, AJ Bojarski, J Ilaš, J Ebner, F Grebien, ... Nature Communications 12 (1), 3201, 2021 | 53 | 2021 |
| Serologic survey of the Crimean-Congo haemorrhagic fever virus infection among wild rodents in Hungary F Földes, M Madai, V Németh, B Zana, H Papp, G Kemenesi, ... Ticks and tick-borne diseases 10 (6), 101258, 2019 | 19 | 2019 |
| Molecular Identification of a Novel Hantavirus in Malaysian Bronze Tube-Nosed Bats (Murina aenea) B Zana, G Kemenesi, D Buzás, G Csorba, T Görföl, FAA Khan, ... Viruses 11 (10), 887, 2019 | 19 | 2019 |
| Methylene blue is a nonspecific protein–protein interaction inhibitor with potential for repurposing as an antiviral for COVID-19 ST Chuang, H Papp, A Kuczmog, R Eells, JM Condor Capcha, ... Pharmaceuticals 15 (5), 621, 2022 | 18 | 2022 |
| The anti-histamine azelastine, identified by computational drug repurposing, inhibits infection by major variants of SARS-CoV-2 in cell cultures and reconstituted human nasal … R Konrat, H Papp, J Kimpel, A Rössler, V Szijártó, G Nagy, M Madai, ... Frontiers in Pharmacology 13, 861295, 2022 | 17 | 2022 |
| Natural apocarotenoids and their synthetic glycopeptide conjugates inhibit SARS-CoV-2 replication I Bereczki, H Papp, A Kuczmog, M Madai, V Nagy, A Agócs, G Batta, ... Pharmaceuticals 14 (11), 1111, 2021 | 16 | 2021 |
| The Anti-histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits SARS-CoV-2 Infection in Reconstituted Human Nasal Tissue In Vitro R Konrat, H Papp, V Szijarto, T Gesell, G Nagy, M Madai, S Zeghbib, ... bioRxiv, 2020 | 11 | 2020 |
| Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity S Barsi, H Papp, A Valdeolivas, DJ Tóth, A Kuczmog, M Madai, ... PLoS computational biology 18 (4), e1010021, 2022 | 10 | 2022 |
| Effectiveness regarding hantavirus detection in rodent tissue samples and urine M Madai, G Horváth, R Herczeg, B Somogyi, B Zana, F Földes, ... Viruses 13 (4), 570, 2021 | 10 | 2021 |
| Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria I Bereczki, V Vimberg, E Lőrincz, H Papp, L Nagy, S Kéki, G Batta, ... Scientific reports 12 (1), 16001, 2022 | 9 | 2022 |
| Small interfering RNAs are highly effective inhibitors of Crimean-Congo hemorrhagic fever virus replication in vitro F Földes, M Madai, H Papp, G Kemenesi, B Zana, L Geiger, K Gombos, ... Molecules 25 (23), 5771, 2020 | 8 | 2020 |
| Development of a novel, entirely herbal-based mouthwash effective against common oral bacteria and SARS-CoV-2 B Bencze, V Temesfői, S Das, H Papp, P Kaltenecker, A Kuczmog, ... BMC Complementary Medicine and Therapies 23 (1), 138, 2023 | 6 | 2023 |
| Genetic characterization of a novel picornavirus in Algerian bats: co-evolution analysis of bat-related picornaviruses S Zeghbib, R Herczeg, G Kemenesi, B Zana, K Kurucz, P Urbán, M Madai, ... Scientific Reports 9 (1), 15706, 2019 | 6 | 2019 |
| Favipiravir for the treatment of COVID-19 in elderly patients—what do we know after 2 years of COVID-19? H Papp, Z Lanszki, GM Keserű, F Jakab GeroScience 44 (3), 1263-1268, 2022 | 5 | 2022 |
| Self-refereeing system in ultimate during the joint junior ultimate championship in three different divisions—a different way to promote fair-play? JP Amoroso, L Coelho, H Papp, F Costa, E Christodoulides, W Cools, ... Youth 3 (1), 414-427, 2023 | 3 | 2023 |
| Transcriptome dataset of six human pathogen RNA viruses generated by nanopore sequencing I Prazsák, Z Csabai, G Torma, H Papp, F Földes, G Kemenesi, F Jakab, ... Data in Brief 43, 108386, 2022 | 2 | 2022 |
| Crimean-Congo hemorrhagic fever virus infection triggers the upregulation of the Wnt signaling pathway inhibitor genes H Papp, S Zeghbib, F Földes, K Banfai, M Madai, G Kemenesi, P Urbán, ... Virus genes 56, 508-514, 2020 | 2 | 2020 |
| Teicoplanin Derivatives Impact on West Nile Virus Pathogenesis H Papp, I Bereczki, P Herczegh, M Madai, G Kemenesi, EB Lőrincz, ... Multidisciplinary Digital Publishing Institute Proceedings 50 (1), 126, 2020 | 2 | 2020 |
